南京科佰生物科技有限公司

主營(yíng)產(chǎn)品: atcc代理,ATCC細(xì)胞系,ATCC細(xì)胞株,ATCC細(xì)胞庫購(gòu)買

11

聯(lián)系電話

18066071954

您現(xiàn)在的位置: 南京科佰生物科技有限公司>>藥靶細(xì)胞株>>腫瘤免疫細(xì)胞株>> CBP74070CD86/CHO

公司信息

聯(lián)人:
蔣經(jīng)理
話:
4008750250
機(jī):
18066071954
真:
址:
南京市棲霞區(qū)緯地路9號(hào)
編:
210000
個(gè)化:
www.co-bioer.com
網(wǎng)址:
www.cobioer.com/
鋪:
http://true-witness.com/st281842/
給他留言
CBP74070CD86/CHO
CD86/CHO
參考價(jià) 面議
具體成交價(jià)以合同協(xié)議為準(zhǔn)
  • 型號(hào) CBP74070
  • 品牌 cobioer/科佰生物
  • 廠商性質(zhì) 代理商
  • 所在地 南京市

更新時(shí)間:2022-07-27 17:26:52瀏覽次數(shù):635

聯(lián)系我們時(shí)請(qǐng)說明是化工儀器網(wǎng)上看到的信息,謝謝!

【簡(jiǎn)單介紹】
供貨周期 現(xiàn)貨 規(guī)格 T-25 Flask
貨號(hào) CBP74070 應(yīng)用領(lǐng)域 生物產(chǎn)業(yè)
主要用途 僅限科研使用
CD86/CHO,凍存條件:90% FBS+10% DMSO
【詳細(xì)說明】
CBP74070
I. Background
B7-2 (CD86) signaling through CTLA4 (CD152) has been shown to inhibit T- cell activation. This co-inhibitory pathway can be overactive in many tumors, enabling cancers to escape the host’s immune system. CTLA4-blocking antibodies, including Ipilimumab (Yervoy) and Tremelimumab, have shown clinical efficacy in treating cancer.
II. Description

Recombinant CHO cells constitutively expressing human CD86.

III. Introduction
Host Cell:CHO
Expressed gene:CD86
Stability:32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)
Synonym(s):

T-lymphocyte activation antigen CD86, B7.2, FUN-1, B70, BU63, CD86, B72

Freeze Medium:90% FBS+10% DMSO
Culture Medium:F12K+10%FBS+500ug/ml hygromycin
Mycoplasma Testing:Negative
Storage:Liquid nitrogen
Application(s):Ligand of CD28&Binding Assay,FACS
IV. Description of Host Cell Line
Organism:Cricetulus griseus, hamster, Chinese
Tissue:Ovary
Disease: Hamster Chinese ovary
Morphology: Epitheloid cell
Growth Properties: Adherent
Ⅴ. Representative Data


CBP74070.png

Figure 1. Recombinant CHO cells expressing human CD86.








產(chǎn)品對(duì)比 產(chǎn)品對(duì)比 二維碼 在線交流

掃一掃訪問手機(jī)商鋪

對(duì)比框

在線留言